ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,905Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 434

$778K Total Retail Price of All Prescriptions

Rank: 12 out of 434

1,190 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,190 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 1,190 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 21,873 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,402 1,314 1 1
SIMVASTATIN 1,235 1,147 2 2
OMEPRAZOLE 1,080 1,005 3 5
LEVOTHYROXINE SODIUM 1,021 917 4 3
HYDROCODONE-ACETAMINOPHEN 944 807 S3 5 4
AMLODIPINE BESYLATE 912 851 6 6
PRAVASTATIN SODIUM 773 713 7 17
ALENDRONATE SODIUM 563 539 8 15
METFORMIN HCL 513 464 9 7
METOPROLOL SUCCINATE 486 471 10 22
LOVASTATIN 429 413 11 10
FENOFIBRATE 421 345 12 43
ATENOLOL 404 379 13 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 372 343 14 21
GABAPENTIN 354 310 15 14
WARFARIN SODIUM 346 337 16 18
METOPROLOL TARTRATE 315 288 17 12
VENTOLIN HFA 313 287 18 30
ATORVASTATIN CALCIUM 307 281 19 19
FUROSEMIDE 307 299 19 9
TERAZOSIN HCL 290 285 21 40
LOSARTAN POTASSIUM 281 263 22 13
ZOLPIDEM TARTRATE 277 257 23 11
GLIMEPIRIDE 265 239 24 58
CARVEDILOL 260 242 25 24
ALLOPURINOL 221 197 26 25
DONEPEZIL HCL 212 208 27 35
FINASTERIDE 212 212 27 54
CITALOPRAM HBR 192 182 29 23
SERTRALINE HCL 192 171 29 27
TRIAMTERENE-HCTZ 191 191 31 47
POTASSIUM CHLORIDE 183 174 32 20
CLOPIDOGREL 179 158 33 41
TAMSULOSIN HCL 177 164 34 29
LOSARTAN-HYDROCHLOROTHIAZIDE 174 165 35 39
FLUTICASONE PROPIONATE 170 167 36 26
PLAVIX 159 151 37 64
IBUPROFEN 149 135 38 56
FLUOXETINE HCL 149 144 38 32
DIGOXIN 147 147 40 69
OXYCODONE HCL-ACETAMINOPHEN 146 108 S2 41 53
SPIRIVA 137 118 42 36
RANITIDINE HCL 136 132 43 31
GLYBURIDE 133 133 R 44 51
MORPHINE SULFATE ER 132 69 S2 45 50
HYDROCHLOROTHIAZIDE 127 99 46 8
GLIPIZIDE 126 104 47 37
NAPROXEN 120 110 48 75
ISOSORBIDE MONONITRATE ER 116 104 49 68
ROPINIROLE HCL 115 108 50 104
CLONIDINE HCL 112 112 51 63
POLYETHYLENE GLYCOL 3350 109 100 52 81
NAMENDA 106 102 53 72
GLYBURIDE-METFORMIN HCL 104 102 R 54 118
BACLOFEN 103 68 55 77
AMITRIPTYLINE HCL 102 93 R 56 57
BENAZEPRIL HCL 99 99 57 49
LIPITOR 92 90 58 133
PAROXETINE HCL 89 81 59 61
LANTUS SOLOSTAR 88 76 60 71
CIPROFLOXACIN HCL 88 83 60 55
TRAZODONE HCL 87 66 62 33
DICLOFENAC SODIUM 87 84 62 92
TRAMADOL HCL 84 72 64 28
EVISTA 78 78 65 132
OXYCODONE HCL 77 45 S2 66 34
QVAR 75 73 67 90
SYMBICORT 74 66 68 93
MELOXICAM 73 65 69 46
METFORMIN HCL ER 69 69 70 48
NIFEDIPINE ER 68 66 71 86
PEN NEEDLE 66 61 72 83
PREDNISONE 66 61 72 42
OXYCODONE-ACETAMINOPHEN 66 64 S2 72 74
METHYLPREDNISOLONE 65 65 75 89
VERAPAMIL ER 64 62 76 78
ADVAIR DISKUS 64 55 76 52
NOVOLOG FLEXPEN 62 48 78 138
ACTOS 61 61 79 85
DILTIAZEM ER 59 59 80 98
PRIMIDONE 59 57 80 264
ENALAPRIL MALEATE 57 57 82 59
CARISOPRODOL 57 22 R 82 44
FAMOTIDINE 57 55 82 76
DILTIAZEM 24HR ER 56 56 85 103
BENICAR 54 54 86 121
GEMFIBROZIL 53 44 87 62
BENICAR HCT 52 52 88 155
TIZANIDINE HCL 52 40 88 88
RISPERIDONE 50 50 90 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.